Navigation Links
Intellifit(R) Offers Custom-Made Jeans with a High-Tech Twist
Date:2/11/2008

PHILADELPHIA, Feb. 11 /PRNewswire/ -- Most fashion consumers consider custom-made jeans to be a luxury reserved for celebrities and lottery winners. But Intellifit, a leader in proprietary apparel fit technology for retail, is out to change that perception.

This week, the company will begin a test of its "Custom Jeans Center" at its company retail store outside of Philadelphia. Using Intellifit technology, fashion consumers can design their own custom-made jeans with a guarantee of a perfect fit. Retail shopping is by appointment and includes consultation with a fashion advisor.

At the retail location, the consumer enters a see-through Intellifit Virtual Fitting Room that's 8' high and 7' wide. In 15 seconds, safe, low power radio waves collect numerous, accurate body measurements -- a personal "FitPrint(TM)" -- while the consumer remains fully clothed. The customer can choose jeans from a selection of styles and washes and add details such as pocket shape and design, stitching and personalization options.

The FitPrint is transferred electronically from the retail location to the jeans manufacturer, where the garment pieces are custom-cut by computer control. The completed custom jeans are shipped directly to the customer in 3 to 4 weeks.

"Once someone gets a pair of custom-made jeans, it's hard to go back to the rack," said Rob Weber, Intellifit President. "Our process brings retail custom-made jeans into a price point where many more fashion consumers can afford them -- typically starting at under $150. Our test will help us determine the scalability of the process. With a positive result, an international roll-out will be close behind."

About Intellifit

Intellifit currently markets a patented 3D full body scanner that accurately takes over 200 body measurements of a fully clothed person in under 15 seconds. Intellifit's Virtual Fitting Room(TM) represents the only fully clothed scanner in the world, and Intellifit
'/>"/>

SOURCE Intellifit
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. New partnership offers outsourced R&D in membrane biology
2. Census of protein architectures offers new view of history of life
3. NAS report offers new tools to assess health risks from chemicals
4. New class of drug offers hope to treatment-resistant AIDS patients
5. Darwin Symposium at Field Museum offers broad overview of his science and its impact
6. Conference on healthspan offers new opportunities for interdisciplinary collaboration
7. Protein controls blood vessel formation, offers new drug target
8. Genetic breakthrough offers promise in tackling kidney tumors
9. New research offers prioritization plan for reducing nutrient pollution in feeder streams
10. High-tech helmets reveal new information about the impact of hard hits to the head
11. MIT reports new twist in microRNA biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Inc. (NASDAQ: AWRE ), a leading supplier of ... third quarter ended September 30, 2014. Revenue for ... of 40% compared to $4.3 million in the same quarter ... was $4.1 million compared to $1.0 million in the third ... month period was primarily due to: i) a $1.0 million ...
(Date:10/18/2014)... genetic conditions, a certain type of exome sequencing method ... traditional molecular diagnostic methods, according to a study appearing ... to coincide with the American Society of Human Genetics ... region of the genome (the complete set of genes ... has been rapidly applied in research settings and recent ...
(Date:10/17/2014)... available in German . ... few drugs. When treating overdoses, doctors are often limited to ... if there is a combination of drugs involved. So what ... swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from the ... an answer to this question. "The task was to develop ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
... better understanding of brain injury, a way to rejuvenate ... monitor their glaucoma at home, number among this years ... What surprises me every time I walk through ... involving so many NJIT graduate and undergraduate students, said ...
... French . , A new brain-imaging study by ... ghrelin - a stomach hormone, acts on specific regions of ... and eating for pleasure. This study, published in the ... understanding and treating obesity, a condition affecting millions world-wide. ...
... The potential of no-tillage (NT) soils for increasing the soil ... Most of the previous studies about SOC accrual in NT ... depth), and not for the whole soil profile. The lack ... to conclusively ascertain the effects of NT farming on SOC ...
Cached Biology News:NJIT applauds students for studies on brain injury, glaucoma and more 2Hunger hormone: Makes food more attractive 2Finding the real potential of no-till farming for sequestering carbon 2
(Date:10/22/2014)... Diego, CA (PRWEB) October 22, 2014 ... balances from Sartorius, A & D Weighing, Rice ... Sartorius CPA Semi-Micro Balance . The Sartorius CPA ... for an affordable high-quality, precise, and user-friendly laboratory ... manufacturing of laboratory equipment, their laboratory balances are ...
(Date:10/22/2014)... VANCOUVER , Oct. 22, 2014 /PRNewswire/ - iCo ... ICOTF), today announced next steps for its Oral ... findings from its in vitro work ... therapy.  iCo now plans to complete pre clinical ... an initial Phase 1A clinical trial, utilizing approximately ...
(Date:10/20/2014)... 20, 2014 Mapp Biopharmaceutical,s valiant effort ... therapeutic to fight the Ebola outbreak will make ... the production of pharmaceuticals can be, according to ... that while some may be taken aback by ... with industry knowledge are well aware of the ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... P. Horovitz , Ph.D., from its board of directors effective ... in August 2003, and served as its chairman from June ... on the Nominating and Corporate Governance and Audit Committees of ... more than a decade of dedicated service to GenVec, and ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Zola P. Horovitz To Retire From GenVec Board 2
... DIEGO, Jan . 8 Arena Pharmaceuticals, Inc. (Nasdaq: ... to present at the 27th Annual J.P. Morgan Healthcare Conference ... p.m. Eastern Time) at the Westin St. Francis Hotel in ... is scheduled to provide an overview of the company, including ...
... 8 Palomar Medical Technologies, Inc. (Nasdaq: ... of light-based systems for cosmetic treatments, today announced ... the Swedish company Q-MED AB (OMX Nordic Exchange, ... based in Uppsala, Sweden. The international distribution ...
... SAN DIEGO, Jan. 7 Volcano Corporation,(Nasdaq: ... sales of,products for the diagnosis and treatment of coronary ... its previously announced acquisition of,Axsun Technologies, Inc. , ... manufacturer of lasers and optical,engines used in medical Optical ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference 3Palomar and Q-MED AB Terminate International Distribution Agreement 2Palomar and Q-MED AB Terminate International Distribution Agreement 3Palomar and Q-MED AB Terminate International Distribution Agreement 4Palomar and Q-MED AB Terminate International Distribution Agreement 5Volcano Announces Closing of Axsun Technologies Acquisition 2
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor...
Recombinant Rat CINC-2 beta, CF...
SHEEP ANTI FLECAINIDE...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Biology Products: